The minimal effective dose of cis-9-cetylmyristoleate (CMO) in persons presenting with knee joint pain: A double-blind, randomized, placebo-controlled trial

BACKGROUND: Nutraceuticals containing cis-9-cetylmyristoleate (CMO) are used to improve knee pain despite the lack of placebo-controlled studies in humans. The aim of the study was to explore the minimal effective dose of CMO for relieving knee joint pain. METHODS: Twenty-eight subjects with mild de...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sang Chul, Jin, Hyun Seung, Joo, Young, Kim, Yong Chul, Moon, Jee Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
3300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340442/
https://www.ncbi.nlm.nih.gov/pubmed/28248869
http://dx.doi.org/10.1097/MD.0000000000006149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340442/
https://www.ncbi.nlm.nih.gov/pubmed/28248869
http://dx.doi.org/10.1097/MD.0000000000006149

Ejemplares similares